Reza Pakzad1, Abdollah Mohammadian-Hafshejani1, Bahman Khosravi1, Shahin Soltani1, Iraj Pakzad1, Mahdi Mohammadian1, Hamid Salehiniya1, Zohre Momenimovahed1. 1. 1 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran ; 2 Epidemiologist, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran ; 3 Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran ; 4 Department of Microbiology, Medical School, Ilam University Of Medical Sciences, Ilam, Iran ; 5 Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran ; 6 Deputy of Health, Isfahan University of Medical Sciences, Isfahan, Iran ; 7 Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran ; 8 Students' Scientific Research Center, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran ; 9 Qom University of Medical Sciences, Qom, Iran.
Abstract
BACKGROUND: Esophageal cancer is the most common cancer in less developed countries. It is necessary to understand epidemiology of the cancer for planning. The aim of this study was to evaluate the incidence and mortality of esophageal cancer, and its relationship with Human Development Index (HDI) and its components in Asia in 2012. METHODS: This study was an Ecological study, which conducted based on GLOBOCAN project of WHO for Asian counters. We assess the correlation between standardized incidence rates (SIR) and standardized mortality rates (SMR) of esophageal cancer with HDI and its components with using of SPSS18. RESULTS: A total of 337,698 incidence (70.33% were males and 29.87% females. Sex ratio was 2.37) and 296,734 death (69.45% in men and 30.54% in women. The sex ratio was 2.27) esophageal cancer was recorded in Asian countries in 2012. Five countries with the highest SIR and SMR of esophageal cancer were Turkmenistan, Mongolia and Tajikistan, Bangladesh and China respectively. Correlation between HDI and SIR was -0.211 (P=0.159), in men -0.175 (P=0.244) and in women -0.231 (P=0.123). Also between HDI and SMR -0.250 (P=0.094) in men -0.226 (P=0.131) and in women -0.251 (P=0.037). CONCLUSIONS: The incidence of esophageal cancer is more in less developed and developing countries. Statistically significant correlation was not found between standardized incidence and mortality rates of esophageal cancer, and HDI and its dimensions, except for life expectancy at birth.
BACKGROUND:Esophageal cancer is the most common cancer in less developed countries. It is necessary to understand epidemiology of the cancer for planning. The aim of this study was to evaluate the incidence and mortality of esophageal cancer, and its relationship with Human Development Index (HDI) and its components in Asia in 2012. METHODS: This study was an Ecological study, which conducted based on GLOBOCAN project of WHO for Asian counters. We assess the correlation between standardized incidence rates (SIR) and standardized mortality rates (SMR) of esophageal cancer with HDI and its components with using of SPSS18. RESULTS: A total of 337,698 incidence (70.33% were males and 29.87% females. Sex ratio was 2.37) and 296,734 death (69.45% in men and 30.54% in women. The sex ratio was 2.27) esophageal cancer was recorded in Asian countries in 2012. Five countries with the highest SIR and SMR of esophageal cancer were Turkmenistan, Mongolia and Tajikistan, Bangladesh and China respectively. Correlation between HDI and SIR was -0.211 (P=0.159), in men -0.175 (P=0.244) and in women -0.231 (P=0.123). Also between HDI and SMR -0.250 (P=0.094) in men -0.226 (P=0.131) and in women -0.251 (P=0.037). CONCLUSIONS: The incidence of esophageal cancer is more in less developed and developing countries. Statistically significant correlation was not found between standardized incidence and mortality rates of esophageal cancer, and HDI and its dimensions, except for life expectancy at birth.
Authors: Kathleen M Mazor; Douglas W Roblin; Andrew E Williams; Sarah M Greene; Bridget Gaglio; Terry S Field; Mary E Costanza; Paul K J Han; Laura Saccoccio; Josephine Calvi; Erica Cove; Rebecca Cowan Journal: Patient Educ Couns Date: 2012-01-13
Authors: John Oliver L DeLancey; Michael J Thun; Ahmedin Jemal; Elizabeth M Ward Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-11 Impact factor: 4.254
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396